Skip to content

Proteomics study in patients with severe malaria

Evaluation of host immune responses and parasite proteome in patients with severe/complicated malaria

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/08/003876
Enrollment
300
Registered
2013-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Severe malaria(P vivax and P falciparum) Non malarial fever Healthy participants

Interventions

Intervention1: Host immune response: Expression levels of the identified serum protein sample (200 microlitre)in severe malaria patients will help to correlate the identified marker proteins with dise

Sponsors

Department of Biosciences and Bioengineering Indian Institute of Technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of either sex aged 18 to 65 years both inclusive Either gender with a diagnosis of severe/complicated vivax malaria OR with a diagnosis of severe malaria due to mixed infection Confirmed nonmalaria fever patients dengue fever (serum IgM antibody titre) leptospirosis (microscopic agglutination test)and enteric fever (widal test) Healthy volunteers as judged by medical history clinical examination and laboratory investigations Patients or their legally accepted representatives willing to provide written informed consent

Exclusion criteria

Exclusion criteria: Patients with history of significant systematic disease like autoimmune disorders chronic liver diseases psychiatric illness and bleeding disorders etc As judged by history and physical examination Patients with a diagnosis of complications to dengue leptospirosis or any other infectious disease A female patient who is pregnant at enrolling

Design outcomes

Primary

MeasureTime frame
Serum proteome analysis of patients suffering from severe P vivax and P falciparum malaria infections to get mechnistic insights about disease pathogenesis and host immune response Identification of potential serum markers associated with severe versus uncomplicated malaria Correlation of the identified serum markers with disease severity establishment of prognostic host markers of malaria Timepoint: single time

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Nithya Gogtay

Department of Bio sciences and Bioengineering IIT

sanjeeva@iitb.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026